Oriental Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 0.02%
- Ebitda 0.04%
- Net Worth -651.37%
- Total Assets -0.11%
About Oriental Biosciences
Oriental Biosciences Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2014 and has a history of Ten years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pranjal Patel and Vishwesh Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U23209GJ2014PTC079400
-
Company No.
079400
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Mar 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Oriental Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwesh Patel
|
Director | 27-Mar-2014 | Current |
|
Pranjal Patel
|
Director | 25-Mar-2016 | Current |
Financial Performance of Oriental Biosciences.
Oriental Biosciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 651.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oriental Biosciences?
In 2018, Oriental Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Oriental Epc Private LimitedVishwesh Patel is a mutual person
-
Credai - AhmedabadPranjal Patel is a mutual person
-
Oriental Enterprise Private LimitedVishwesh Patel is a mutual person
-
Vivan Ashiyana Realtors LlpPranjal Patel and Vishwesh Patel are mutual person
-
Vps Buildcon Llp
Pranjal Patel and Vishwesh Patel are mutual person
-
Construction India Pvt Ltd
Pranjal Patel and Vishwesh Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oriental Biosciences?
Unlock and access historical data on people associated with Oriental Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriental Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
